Your browser doesn't support javascript.
loading
Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Houten, Rachel; Fleeman, Nigel; Mahon, James; Chaplin, Marty; Edwards, Katherine; Beale, Sophie; Boland, Angela; Dundar, Yenal; Marsden, Ashley; Malik, Zafar; Palmieri, Carlo.
Afiliação
  • Houten R; Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, The Quadrangle, Brownlow Hill, Liverpool, L69 3GB, UK.
  • Fleeman N; Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, The Quadrangle, Brownlow Hill, Liverpool, L69 3GB, UK. nigel.fleeman@liverpool.ac.uk.
  • Mahon J; Coldingham Analytical Services, Berwickshire, UK.
  • Chaplin M; Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, The Quadrangle, Brownlow Hill, Liverpool, L69 3GB, UK.
  • Edwards K; Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, The Quadrangle, Brownlow Hill, Liverpool, L69 3GB, UK.
  • Beale S; Hare Research, North Yorkshire, UK.
  • Boland A; Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, The Quadrangle, Brownlow Hill, Liverpool, L69 3GB, UK.
  • Dundar Y; Liverpool Reviews and Implementation Group, University of Liverpool, Whelan Building, The Quadrangle, Brownlow Hill, Liverpool, L69 3GB, UK.
  • Marsden A; North West Medicines Information Centre, Liverpool, UK.
  • Malik Z; The Clatterbridge Cancer Centre, Liverpool, UK.
  • Palmieri C; The Clatterbridge Cancer Centre, Liverpool, UK.
Pharmacoecon Open ; 7(3): 345-358, 2023 May.
Article em En | MEDLINE | ID: mdl-37084172

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article